Chiral separation of propranolol by electrokinetic chromatography using nanodiamonds and human serum albumin as a pseudo‐stationary phase in river water
Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R‐ and S‐propranolol were determined in river samples by electrokinetic chromatography (EKC) using nanodiamonds (NDs) and human serum albumin (HSA) as a pseudo‐stationary phase in order to achieve enantios...
Saved in:
Published in | Chirality (New York, N.Y.) Vol. 36; no. 2; pp. e23640 - n/a |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.02.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R‐ and S‐propranolol were determined in river samples by electrokinetic chromatography (EKC) using nanodiamonds (NDs) and human serum albumin (HSA) as a pseudo‐stationary phase in order to achieve enantioseparation. Previously, river samples were preconcentrated using a column filled with Amberlite® IR‐120 and Dowex® 50WX8 resins. The setting up of influential factors such as temperature, voltage, pH, and HSA and NDs concentration is accurately described along this manuscript. A multivariate study and optimization was carried out to obtain the enantioseparation of propranolol (Rs = 2.91), which was reached under the following experimental conditions: voltage of 16 kV, temperature of 16°C, phosphate buffer pH 9.5, NDs of 0.20%, and HSA of 15 μmol l−1. The recoveries of analytes under optimal conditions were higher than 98%. The limits of detection were 0.85 μg l−1 for R‐ and S‐propranolol. The method was applied to real samples, and the obtained results in three different water sources studied were 1.02, 0.59, and 0.30 μg l−1 for the R‐enantiomer and 0.99, 0.54, and 0.28 μg l−1 for the S‐enantiomer. The accuracy of the proposed methodology (including bias and precision) has allowed us to propose it as a successful tool for the control of water quality.
Scheme of the complete proposed procedure for the separation of the two enantiomers of propranolol, using nanodiamonds and albumin, by capillary electrophoresis. |
---|---|
AbstractList | Abstract Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R ‐ and S ‐propranolol were determined in river samples by electrokinetic chromatography (EKC) using nanodiamonds (NDs) and human serum albumin (HSA) as a pseudo‐stationary phase in order to achieve enantioseparation. Previously, river samples were preconcentrated using a column filled with Amberlite® IR‐120 and Dowex® 50WX8 resins. The setting up of influential factors such as temperature, voltage, pH, and HSA and NDs concentration is accurately described along this manuscript. A multivariate study and optimization was carried out to obtain the enantioseparation of propranolol (Rs = 2.91), which was reached under the following experimental conditions: voltage of 16 kV, temperature of 16°C, phosphate buffer pH 9.5, NDs of 0.20%, and HSA of 15 μmol l −1 . The recoveries of analytes under optimal conditions were higher than 98%. The limits of detection were 0.85 μg l −1 for R ‐ and S ‐propranolol. The method was applied to real samples, and the obtained results in three different water sources studied were 1.02, 0.59, and 0.30 μg l −1 for the R‐ enantiomer and 0.99, 0.54, and 0.28 μg l −1 for the S‐ enantiomer. The accuracy of the proposed methodology (including bias and precision) has allowed us to propose it as a successful tool for the control of water quality. Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R- and S-propranolol were determined in river samples by electrokinetic chromatography (EKC) using nanodiamonds (NDs) and human serum albumin (HSA) as a pseudo-stationary phase in order to achieve enantioseparation. Previously, river samples were preconcentrated using a column filled with Amberlite® IR-120 and Dowex® 50WX8 resins. The setting up of influential factors such as temperature, voltage, pH, and HSA and NDs concentration is accurately described along this manuscript. A multivariate study and optimization was carried out to obtain the enantioseparation of propranolol (Rs = 2.91), which was reached under the following experimental conditions: voltage of 16 kV, temperature of 16°C, phosphate buffer pH 9.5, NDs of 0.20%, and HSA of 15 μmol l-1 . The recoveries of analytes under optimal conditions were higher than 98%. The limits of detection were 0.85 μg l-1 for R- and S-propranolol. The method was applied to real samples, and the obtained results in three different water sources studied were 1.02, 0.59, and 0.30 μg l-1 for the R-enantiomer and 0.99, 0.54, and 0.28 μg l-1 for the S-enantiomer. The accuracy of the proposed methodology (including bias and precision) has allowed us to propose it as a successful tool for the control of water quality. Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R- and S-propranolol were determined in river samples by electrokinetic chromatography (EKC) using nanodiamonds (NDs) and human serum albumin (HSA) as a pseudo-stationary phase in order to achieve enantioseparation. Previously, river samples were preconcentrated using a column filled with Amberlite® IR-120 and Dowex® 50WX8 resins. The setting up of influential factors such as temperature, voltage, pH, and HSA and NDs concentration is accurately described along this manuscript. A multivariate study and optimization was carried out to obtain the enantioseparation of propranolol (Rs = 2.91), which was reached under the following experimental conditions: voltage of 16 kV, temperature of 16°C, phosphate buffer pH 9.5, NDs of 0.20%, and HSA of 15 μmol l . The recoveries of analytes under optimal conditions were higher than 98%. The limits of detection were 0.85 μg l for R- and S-propranolol. The method was applied to real samples, and the obtained results in three different water sources studied were 1.02, 0.59, and 0.30 μg l for the R-enantiomer and 0.99, 0.54, and 0.28 μg l for the S-enantiomer. The accuracy of the proposed methodology (including bias and precision) has allowed us to propose it as a successful tool for the control of water quality. Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R‐ and S‐propranolol were determined in river samples by electrokinetic chromatography (EKC) using nanodiamonds (NDs) and human serum albumin (HSA) as a pseudo‐stationary phase in order to achieve enantioseparation. Previously, river samples were preconcentrated using a column filled with Amberlite® IR‐120 and Dowex® 50WX8 resins. The setting up of influential factors such as temperature, voltage, pH, and HSA and NDs concentration is accurately described along this manuscript. A multivariate study and optimization was carried out to obtain the enantioseparation of propranolol (Rs = 2.91), which was reached under the following experimental conditions: voltage of 16 kV, temperature of 16°C, phosphate buffer pH 9.5, NDs of 0.20%, and HSA of 15 μmol l−1. The recoveries of analytes under optimal conditions were higher than 98%. The limits of detection were 0.85 μg l−1 for R‐ and S‐propranolol. The method was applied to real samples, and the obtained results in three different water sources studied were 1.02, 0.59, and 0.30 μg l−1 for the R‐enantiomer and 0.99, 0.54, and 0.28 μg l−1 for the S‐enantiomer. The accuracy of the proposed methodology (including bias and precision) has allowed us to propose it as a successful tool for the control of water quality. Scheme of the complete proposed procedure for the separation of the two enantiomers of propranolol, using nanodiamonds and albumin, by capillary electrophoresis. Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R‐ and S‐propranolol were determined in river samples by electrokinetic chromatography (EKC) using nanodiamonds (NDs) and human serum albumin (HSA) as a pseudo‐stationary phase in order to achieve enantioseparation. Previously, river samples were preconcentrated using a column filled with Amberlite® IR‐120 and Dowex® 50WX8 resins. The setting up of influential factors such as temperature, voltage, pH, and HSA and NDs concentration is accurately described along this manuscript. A multivariate study and optimization was carried out to obtain the enantioseparation of propranolol (Rs = 2.91), which was reached under the following experimental conditions: voltage of 16 kV, temperature of 16°C, phosphate buffer pH 9.5, NDs of 0.20%, and HSA of 15 μmol l−1. The recoveries of analytes under optimal conditions were higher than 98%. The limits of detection were 0.85 μg l−1 for R‐ and S‐propranolol. The method was applied to real samples, and the obtained results in three different water sources studied were 1.02, 0.59, and 0.30 μg l−1 for the R‐enantiomer and 0.99, 0.54, and 0.28 μg l−1 for the S‐enantiomer. The accuracy of the proposed methodology (including bias and precision) has allowed us to propose it as a successful tool for the control of water quality. |
Author | Lanaro, Verónica M. Stege, Patricia W. Almeida, César A. Altamirano, Jorgelina C. Sombra, Lorena L. |
Author_xml | – sequence: 1 givenname: Verónica M. surname: Lanaro fullname: Lanaro, Verónica M. organization: Universidad Nacional de San Luis – sequence: 2 givenname: Lorena L. surname: Sombra fullname: Sombra, Lorena L. organization: Universidad Nacional de San Luis – sequence: 3 givenname: Jorgelina C. surname: Altamirano fullname: Altamirano, Jorgelina C. organization: CONICET (Consejo Nacional de Investigaciones Científicas y Tecnológicas) – sequence: 4 givenname: César A. surname: Almeida fullname: Almeida, César A. organization: CONICET (Consejo Nacional de Investigaciones Científicas y Tecnológicas) – sequence: 5 givenname: Patricia W. surname: Stege fullname: Stege, Patricia W. email: pwstege@gmail.com organization: IMIBIO‐SL, Instituto Multidisciplinario de Investigación Biológica |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38384157$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcFu1DAQhi1URLcLFx4AWeKCkFLs2OskR7QCWqkSEgKJWzSxJ42LYwc7odobj8CZx-NJcLqFAwcunoO_-Tzj_4yc-OCRkKecnXPGyld6sPG8FEqyB2TDdyUrlFCfT8iG1U1TMCbLU3KW0g1jrFFCPiKnoha15LtqQ37uczM4mnCCCLMNnoaeTjFMEXxwwdHuQNGhnmP4Yj3OVlM9xDDCHK4jTMOBLsn6a-ozbiyMwZtEwRs6LCP47I3LSMF1y2g9hXxFp4SLCb--_0jz3YMQD3QaICHNRLTfMNJbmDE-Jg97cAmf3Nct-fT2zcf9RXH1_t3l_vVVoQVXrNCq47WsVVU2AqteQKfKnhuDokRZC8NLQMOwklUn2K7qtW4qwPUDjKwN42JLXhy9eeuvC6a5HW3S6Bx4DEtqs5fJSjVSZPT5P-hNWKLP02Vq5er13JKXR0rHkFLEvp2iHfOaLWftmli7JtbeJZbhZ_fKpRvR_EX_RJQBfgRurcPDf1Tt_uLyw1H6GxVjpxI |
Cites_doi | 10.1007/s10337‐011‐2176‐2 10.1002/elps.200900173 10.1039/C6RA10583A 10.1016/0006‐2952(86)90091‐2 10.2174/0929867323666160907111107 10.1016/j.trac.2016.11.004 10.1016/j.aca.2007.04.029 10.1002/elps.200305575 10.1016/S0003‐2670(99)00105‐1 10.1002/jps.2600710623 10.1016/S0021‐9673(00)00504‐5 10.1002/elps.201200239 10.1016/0005‐2795(79)90075‐8 10.1016/j.trac.2014.05.011 10.1002/(SICI)1522‐2683(19990701)20:9<1869::AID‐ELPS1869>3.0.CO;2‐3 10.1016/S0021‐9673(00)00066‐2 10.1039/c3ay40541a 10.1016/j.chroma.2008.07.071 10.1016/j.scitotenv.2014.06.039 10.1016/j.chroma.2016.05.061 10.1016/S0065‐3233(08)60640‐3 10.1016/j.diamond.2017.03.007 10.1002/chir.22414 10.1002/elps.200900288 10.1002/elps.200800607 10.1016/j.jchromb.2003.08.035 10.1016/j.talanta.2014.01.034 10.1016/0006‐2952(88)90072‐X 10.1007/s00244‐002‐1182‐7 10.1002/bmc.1252 10.1002/elps.200500304 10.1016/j.jpba.2011.04.023 10.1002/jssc.201600182 10.1002/jez.672 10.1002/elps.201100153 10.1007/s11356‐018‐2123‐y 10.1016/j.aca.2003.11.029 10.1016/0167‐4838(88)90007‐6 10.1016/j.talanta.2008.05.019 |
ContentType | Journal Article |
Copyright | 2024 Wiley Periodicals LLC. 2024 Wiley Periodicals LLC |
Copyright_xml | – notice: 2024 Wiley Periodicals LLC. – notice: 2024 Wiley Periodicals LLC |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7QR 7U7 8FD C1K FR3 P64 7X8 |
DOI | 10.1002/chir.23640 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Chemoreception Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts Chemoreception Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Biotechnology Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1520-636X |
EndPage | n/a |
ExternalDocumentID | 10_1002_chir_23640 38384157 CHIR23640 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Secretaria de Ciencia y Técnica from the Universidad Nacional de San Luis funderid: PROICO 2‐3818 – fundername: Agencia Nacional de Promoción Científica y Tecnológica funderid: PICT 2017‐1091 – fundername: Consejo Nacional de Investigaciones Científicas y Técnicas funderid: CONICET 112‐201101‐00123 – fundername: Instituto de Química de San Luis – fundername: Universidad Nacional de San Luis – fundername: Consejo Nacional de Investigaciones Científicas y Técnicas grantid: CONICET 112-201101-00123 – fundername: Agencia Nacional de Promoción Científica y Tecnológica grantid: PICT 2017-1091 – fundername: Secretaria de Ciencia y Técnica from the Universidad Nacional de San Luis grantid: PROICO 2-3818 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 29B 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABIJN ABOCM ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AI. AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BTSUX BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M21 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2W P2X P4D PALCI Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RWK RX1 RYL SAMSI SUPJJ TUS UB1 UPT V2E V8K VH1 W8V W99 WBFHL WBKPD WIB WIH WIK WJL WOHZO WQJ WRC WXSBR WYISQ XG1 XV2 YCJ ZZTAW ~02 ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7QR 7U7 8FD C1K FR3 P64 7X8 |
ID | FETCH-LOGICAL-c3160-c6b184867293e7f3ab62f1dde32e483d12aed0e747b3057fcc97ae8384d48d013 |
IEDL.DBID | DR2 |
ISSN | 0899-0042 |
IngestDate | Fri Aug 16 05:08:02 EDT 2024 Thu Oct 10 22:18:02 EDT 2024 Wed Aug 28 12:34:42 EDT 2024 Tue Oct 29 09:21:30 EDT 2024 Sat Aug 24 00:56:08 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | enantioseparation electrokinetic chromatography human serum albumin nanodiamonds propranolol |
Language | English |
License | 2024 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3160-c6b184867293e7f3ab62f1dde32e483d12aed0e747b3057fcc97ae8384d48d013 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 38384157 |
PQID | 2929308929 |
PQPubID | 986330 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2930476943 proquest_journals_2929308929 crossref_primary_10_1002_chir_23640 pubmed_primary_38384157 wiley_primary_10_1002_chir_23640_CHIR23640 |
PublicationCentury | 2000 |
PublicationDate | February 2024 2024-Feb 2024-02-00 20240201 |
PublicationDateYYYYMMDD | 2024-02-01 |
PublicationDate_xml | – month: 02 year: 2024 text: February 2024 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Chichester |
PublicationTitle | Chirality (New York, N.Y.) |
PublicationTitleAlternate | Chirality |
PublicationYear | 2024 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2009; 23 2017; 86 2011; 315 1982; 71 2000; 875 1999; 391 1986; 35 1988; 37 2017; 24 1994; 45 1997 2016; 1467 1996 2011; 32 1999; 20 2005 2008; 76 2011; 56 2003; 797 2005; 26 2016; 39 2014; 493 2014; 61 2013; 5 2012; 75 2004; 507 2016; 6 2017; 74 2018; 270 2018; 1204 2009; 30 2015; 27 2013; 34 1979; 579 2007; 592 2002; 43 2011; 906 2003; 24 1988; 953 2014; 124 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 (e_1_2_7_42_1) 2005 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 Peters T (e_1_2_7_37_1) 1996 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 McNaught AD (e_1_2_7_35_1) 1997 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_20_1 e_1_2_7_36_1 Aboul‐Enein HY (e_1_2_7_4_1) 1997 e_1_2_7_38_1 e_1_2_7_39_1 |
References_xml | – volume: 391 start-page: 127 issue: 2 year: 1999 end-page: 134 article-title: Detection and quantification limits: origins and historical overview publication-title: Anal Chim Acta – volume: 23 start-page: 1291 issue: 12 year: 2009 end-page: 1299 article-title: Reversed‐phase high‐performance liquid chromatographic enantioresolution of six β‐blockers using dinitrophenyl‐ ‐pro‐ ‐hydroxysuccinimide ester, ‐succinimidyl‐( )‐2‐(6‐methoxynaphth‐2‐yl) propionate and twelve variants of Sanger's reagent as chiral derivatizing reagents publication-title: Biomed Chromatogr – volume: 315 start-page: 251 issue: 5 year: 2011 end-page: 265 article-title: β‐Blockers as endocrine disruptors: the potential effects of human β‐blockers on aquatic organisms publication-title: J Exp Zool a Ecol Genet Physiol – volume: 24 start-page: 796 issue: 8 year: 2017 end-page: 817 article-title: Laboratory‐scale preparative enantioseparations of pharmaceutically relevant compounds on commercially available chiral stationary phases for HPLC publication-title: Curr Med Chem – volume: 75 start-page: 181 issue: 3‐4 year: 2012 end-page: 185 article-title: Enantioseparation of three β‐agonists using di‐ ‐butyl ‐tartrate‐boric acid complex as chiral selector by means of MEEKC publication-title: Chromatographia – year: 2005 – volume: 20 start-page: 1869 issue: 9 year: 1999 end-page: 1877 article-title: Study of enantioselective interactions between chiral drugs and serum albumin by capillary electrophoresis publication-title: Electrophoresis – volume: 56 start-page: 141 issue: 2 year: 2011 end-page: 158 article-title: Experimental designs and their recent advances in set‐up, data interpretation, and analytical applications publication-title: J Pharm Biomed Anal – volume: 953 start-page: 37 issue: 1 year: 1988 end-page: 47 article-title: Mechanism by which warfarin binds to human serum albumin. Stopped‐flow kinetic experiments with two large fragments of albumin publication-title: Biochim Biophys Acta – volume: 30 start-page: 3964 issue: 22 year: 2009 end-page: 3970 article-title: Functionalized carbon nanotubes as the pseudostationary phase for capillary EKC separation of non‐steroidal anti‐inflammatory drugs publication-title: Electrophoresis – year: 1996 – volume: 797 start-page: 131 issue: 1‐2 year: 2003 end-page: 159 article-title: Separation of drug enantiomers by liquid chromatography and capillary electrophoresis, using immobilized proteins as chiral selectors publication-title: J Chromatogr B – volume: 35 start-page: 1005 issue: 6 year: 1986 end-page: 1009 article-title: Evidence for distinct consecutive steps in the neutral to base transition of human serum albumin publication-title: Biochem Pharmacol – volume: 32 start-page: 2602 issue: 19 year: 2011 end-page: 2628 article-title: Advances in the enantioseparation of β‐blocker drugs by capillary electromigration techniques publication-title: Electrophoresis – volume: 30 start-page: 100 issue: 1 year: 2009 end-page: 132 article-title: Advances in enantioselective separations using electromigration capillary techniques publication-title: Electrophoresis – volume: 1467 start-page: 56 year: 2016 end-page: 78 article-title: Chiral recognition in separation science—an update publication-title: J Chromatogr a – volume: 507 start-page: 171 issue: 2 year: 2004 end-page: 178 article-title: Fast enantiomeric separation of propranolol by affinity capillary electrophoresis using human serum albumin as chiral selector: application to quality control of pharmaceuticals publication-title: Anal Chim Acta – volume: 43 start-page: 229 issue: 2 year: 2002 end-page: 235 article-title: Toxicity of select beta adrenergic receptor‐blocking pharmaceuticals (β‐blockers) on aquatic organisms publication-title: Arch Environ Contam Toxicol – volume: 592 start-page: 202 issue: 2 year: 2007 end-page: 209 article-title: Enantiomeric quality control of antihistamines in pharmaceuticals by affinity electrokinetic chromatography with human serum albumin as chiral selector publication-title: Anal Chim Acta – volume: 6 start-page: 80576 issue: 84 year: 2016 end-page: 80584 article-title: A validated gas chromatography mass spectrometry method for simultaneous determination of cathinone related drug enantiomers in urine and plasma publication-title: RSC Adv – volume: 579 start-page: 469 issue: 2 year: 1979 end-page: 473 article-title: Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements publication-title: Biochim Biophys Acta – volume: 37 start-page: 3905 issue: 20 year: 1988 end-page: 3909 article-title: Location and characterization of the warfarin binding site of human serum albumin. A comparative study of two large fragments publication-title: Biochem Pharmacol – volume: 270 start-page: 1 issue: 20 year: 2018 end-page: 13 article-title: Determination of nine pharmaceutical active compounds in surface waters from Paraopeba River Basin in Brazil by LTPE‐HPLC‐ESI‐MS/MS publication-title: Environ Sci Pollut Res – volume: 27 start-page: 211 issue: 3 year: 2015 end-page: 215 article-title: Indirect chiral separation of new recreational drugs by gas chromatography‐mass spectrometry using trifluoroacetyl‐ ‐prolyl chloride as chiral derivatization reagent publication-title: Chirality – volume: 30 start-page: 2773 issue: 16 year: 2009 end-page: 2802 article-title: Advanced CE for chiral analysis of drugs, metabolites, and biomarkers in biological samples publication-title: Electrophoresis – volume: 74 start-page: 191 year: 2017 end-page: 196 article-title: Nanodiamonds stabilized in dihexadecyl phosphate film for electrochemical study and quantification of codeine in biological and pharmaceutical samples publication-title: Diamond Relat Mater – volume: 26 start-page: 4116 issue: 21 year: 2005 end-page: 4126 article-title: Multivariate optimization approach for chiral resolution of drugs using human serum albumin in affinity electrokinetic chromatography–partial filling technique publication-title: Electrophoresis – volume: 906 start-page: 253 issue: 1‐2 year: 2011 end-page: 273 article-title: Protein‐based chiral stationary phases for high‐performance liquid chromatography enantioseparations publication-title: J Chromatogr a – volume: 875 start-page: 255 issue: 1‐2 year: 2000 end-page: 276 article-title: Enantiomer separation of chiral pharmaceuticals by capillary electrochromatography publication-title: J Chromatogr a – volume: 45 start-page: 153 year: 1994 end-page: 203 article-title: Structure of serum albumin publication-title: Adv Protein Chem – year: 1997 – volume: 1204 start-page: 140 issue: 2 year: 2018 end-page: 156 article-title: Chiral separation by capillary electromigration techniques publication-title: J Chromatogr a – volume: 124 start-page: 123 year: 2014 end-page: 138 article-title: Experimental design and multiple response optimization. Using the desirability function in analytical methods development publication-title: Talanta – volume: 61 start-page: 29 year: 2014 end-page: 39 article-title: Applications of nanoparticle‐modified stationary phases in capillary electrochromatography publication-title: Trends Anal Chem – volume: 76 start-page: 965 issue: 5 year: 2008 end-page: 977 article-title: Response surface methodology (RSM) as a tool for optimization in analytical chemistry publication-title: Talanta – volume: 34 start-page: 178 issue: 1 year: 2013 end-page: 204 article-title: Chiral selectors in CE: recent developments and applications publication-title: Electrophoresis – volume: 5 start-page: 3864 issue: 16 year: 2013 end-page: 3871 article-title: Nanodiamonds assisted‐cloud point extraction for the determination of fluoranthene in river water publication-title: Anal Methods – volume: 24 start-page: 4181 issue: 24 year: 2003 end-page: 4188 article-title: Carbon nanotubes as separation carrier in capillary electrophoresis publication-title: Electrophoresis – volume: 71 start-page: 699 issue: 6 year: 1982 end-page: 704 article-title: Stereoselective disposition and glucuronidation of propranolol in humans publication-title: J Pharm Sci – volume: 493 start-page: 1122 year: 2014 end-page: 1126 article-title: Beta‐blockers in the environment: part II. Ecotoxicity study publication-title: Sci Total Environ – volume: 39 start-page: 3246 issue: 16 year: 2016 end-page: 3253 article-title: Determination of the stereoisomers in aqueous medium and serum and validation studies of racemic aminoalkanol derivatives of 1,7‐dimethyl‐8,9‐diphenyl‐4‐azatricyclo[5.2.1.0 ]dec‐8‐ene‐3,5,10‐trione, potential new anticancer drugs, by capillary electrophoresis publication-title: J Sep Sci – volume: 86 start-page: 56 year: 2017 end-page: 74 article-title: Nanoparticle improved separations: from capillary to slab gel electrophoresis publication-title: Trends Anal Chem – ident: e_1_2_7_6_1 doi: 10.1007/s10337‐011‐2176‐2 – ident: e_1_2_7_16_1 doi: 10.1002/elps.200900173 – ident: e_1_2_7_13_1 doi: 10.1039/C6RA10583A – ident: e_1_2_7_39_1 doi: 10.1016/0006‐2952(86)90091‐2 – volume-title: The Impact of Stereochemistry on Drug Development and Use year: 1997 ident: e_1_2_7_4_1 contributor: fullname: Aboul‐Enein HY – ident: e_1_2_7_10_1 doi: 10.2174/0929867323666160907111107 – ident: e_1_2_7_27_1 doi: 10.1016/j.trac.2016.11.004 – ident: e_1_2_7_28_1 doi: 10.1016/j.aca.2007.04.029 – ident: e_1_2_7_22_1 doi: 10.1002/elps.200305575 – volume-title: International Conference on Harmonisation (ICH), Q2 (R1): Validation of Analytical Procedures: Text and Methodology year: 2005 ident: e_1_2_7_42_1 – ident: e_1_2_7_33_1 doi: 10.1016/S0003‐2670(99)00105‐1 – volume-title: All About Albumin: Biochemistry, Genetics, and Medical Applications year: 1996 ident: e_1_2_7_37_1 contributor: fullname: Peters T – ident: e_1_2_7_3_1 doi: 10.1002/jps.2600710623 – ident: e_1_2_7_9_1 doi: 10.1016/S0021‐9673(00)00504‐5 – ident: e_1_2_7_14_1 doi: 10.1002/elps.201200239 – ident: e_1_2_7_38_1 doi: 10.1016/0005‐2795(79)90075‐8 – ident: e_1_2_7_24_1 doi: 10.1016/j.trac.2014.05.011 – ident: e_1_2_7_30_1 doi: 10.1002/(SICI)1522‐2683(19990701)20:9<1869::AID‐ELPS1869>3.0.CO;2‐3 – ident: e_1_2_7_18_1 doi: 10.1016/S0021‐9673(00)00066‐2 – ident: e_1_2_7_26_1 doi: 10.1039/c3ay40541a – ident: e_1_2_7_15_1 doi: 10.1016/j.chroma.2008.07.071 – ident: e_1_2_7_7_1 doi: 10.1016/j.scitotenv.2014.06.039 – ident: e_1_2_7_21_1 doi: 10.1016/j.chroma.2016.05.061 – ident: e_1_2_7_36_1 doi: 10.1016/S0065‐3233(08)60640‐3 – ident: e_1_2_7_25_1 doi: 10.1016/j.diamond.2017.03.007 – ident: e_1_2_7_12_1 doi: 10.1002/chir.22414 – ident: e_1_2_7_23_1 doi: 10.1002/elps.200900288 – ident: e_1_2_7_17_1 doi: 10.1002/elps.200800607 – ident: e_1_2_7_19_1 doi: 10.1016/j.jchromb.2003.08.035 – ident: e_1_2_7_44_1 doi: 10.1016/j.talanta.2014.01.034 – ident: e_1_2_7_40_1 doi: 10.1016/0006‐2952(88)90072‐X – ident: e_1_2_7_32_1 doi: 10.1007/s00244‐002‐1182‐7 – ident: e_1_2_7_5_1 doi: 10.1002/bmc.1252 – ident: e_1_2_7_29_1 doi: 10.1002/elps.200500304 – ident: e_1_2_7_34_1 doi: 10.1016/j.jpba.2011.04.023 – ident: e_1_2_7_20_1 doi: 10.1002/jssc.201600182 – ident: e_1_2_7_8_1 doi: 10.1002/jez.672 – ident: e_1_2_7_2_1 doi: 10.1002/elps.201100153 – ident: e_1_2_7_11_1 doi: 10.1007/s11356‐018‐2123‐y – ident: e_1_2_7_31_1 doi: 10.1016/j.aca.2003.11.029 – ident: e_1_2_7_41_1 doi: 10.1016/0167‐4838(88)90007‐6 – volume-title: Compendium of Chemical Terminology year: 1997 ident: e_1_2_7_35_1 contributor: fullname: McNaught AD – ident: e_1_2_7_43_1 doi: 10.1016/j.talanta.2008.05.019 |
SSID | ssj0009634 |
Score | 2.43015 |
Snippet | Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R‐ and S‐propranolol were determined in river samples by... Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R- and S-propranolol were determined in river samples by... Abstract Propranolol is currently considered as an emerging contaminant in water bodies. In this study, R ‐ and S ‐propranolol were determined in river samples... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e23640 |
SubjectTerms | Amberlite (trademark) Chromatography Chromatography, Micellar Electrokinetic Capillary - methods Contaminants Diamonds Electric potential electrokinetic chromatography Electrokinetics Enantiomers enantioseparation Human serum albumin Humans Nanodiamonds Nanostructure Propranolol Resins Rivers Serum albumin Serum Albumin, Human Stationary phase Stereoisomerism Voltage Water pollution Water quality Water quality control Water sampling |
Title | Chiral separation of propranolol by electrokinetic chromatography using nanodiamonds and human serum albumin as a pseudo‐stationary phase in river water |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fchir.23640 https://www.ncbi.nlm.nih.gov/pubmed/38384157 https://www.proquest.com/docview/2929308929 https://search.proquest.com/docview/2930476943 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VvcCFR8sjtKBBIA5I2SZxXitxqRaqBQkOFZV6QZFfYatSZ5VsVJUTP4EzP49fwthOdlWQkOAWKRPHcWY839jjbwCe8yS2fi8LC8LGdpsxs5uEdThVEa9lLGUa2fPO7z_k85P03Wl2ugWvxrMwnh9iveBmLcPN19bAuegONqShcnHWTiz9uQ3YY1bYfK7XxxvuKNIsxx1V2mP2pJprbtLkYPPodW_0B8S8jlidyzm6DZ_GzvpMk_NJvxIT-fU3Hsf__Zo7cGvAonjolecubGmzA7uHhuLwiyt8gS471C2778CN2VgZbhd-zKgZerDTnji8MdjUSN1ckuMj-S8ornCor3NOPaPmUS7ahsDxQJCNNt3-MxoSJ_0kS1AdcqPQVQykdtv-Al3i9JlBTrdw2eleNT-_fe986gB9KC4X5IGRJFqbW4KXhJrbe3By9ObjbB4ONR5CyeI8CmUuKMYsc8L4TBc14yJP6pjmXJbotGQqTrhWkaagR9DMVNRSTguuS1amKi0V4df7sG0aox8CxnVWS1t_KxVRKrgSWSxKgkd5KShq1SqAZ-O_rpaeyqPypM1JZYe_csMfwP6oBtVgzl2VEIhkpEnJNICn69s06nZ3hRvd9FbG7mDm05QF8MCrz_o1zHY4zooAXjol-Mv7q9n87bG7evQvwntwMyG45fPJ92F71fb6McGllXjizOIXL6kUWg |
link.rule.ids | 315,783,787,1378,27938,27939,46308,46732 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZQeygXKC2P0AKDQByQsk3svPZYLVRbaHuoWqm3KH6kW5U6q2Sjqj31J3Dm5_FLmHGyuypISHCLlInjODOeb-zxN4y9L3hIfi_2U8TGtM0Y0yZh6Q91UJQqVCoK6Lzz4VEyPo2-nMVnfW4OnYXp-CEWC25kGW6-JgOnBemdJWuomlzUA-I_x4h9Fe1dUAGDT8dL9ijULcceldFBe1TOBTsp31k-e98f_QEy72NW53T2HneVVRvHVUi5JpeDdiYH6vY3Jsf__p519qiHo7Db6c8T9sDYDba5azEUv7qBD-ASRN3K-wZbG82Lw22yHyNsBh9sTMcdXlmoSsB-TtH3ofw3kDfQl9i5xK5h86AmdYX4uOfIBsq4PweL4qiiaAy6gcJqcEUDsd26vQKXO31hocBbMG1Mq6ufd9-bLnsAvxSmE3TCgBI1pZfANQLn-ik73ft8Mhr7fZkHX4kwCXyVSAwzswRhvjBpKQqZ8DLEaVdwE2VCh7wwOjAY90icnNJSqWFamExkkY4yjRD2GVuxlTUvGIRlXCoqwRXJIJKFlnEoM0RISSYxcDXaY-_mPzufdmweecfbzHMa_twNv8e253qQ9xbd5BxxpEBV4kOPvV3cxlGnDZbCmqolGdrETIaR8NjzTn8WrxHU4TBOPfbRacFf3p-PxvvH7urlvwi_YWvjk8OD_GD_6OsWe8gRfXXp5dtsZVa35hWip5l87WzkF08NGHQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB5KBfXFS6s1WnVE8UHIae7Jgb6UUw-nXooUC32RkL15Su0mJCdIffIn-OzP6y9xdpOcQxUEfQmBTDabzczON9nZbwBeFIFv_F7spoSNzTJjbBYJlTsWXqG4z3nkmf3O7w-T2XH05iQ-WYPdYS9Mxw-x_OFmLMPO18bAK6F2VqShfH5ajwz9OQXs16Ik9ExC1_7RijyKVMuSR2Vmnz3p5pKcNNhZ3XvVHf2BMa9CVutzprfh09DbLtXkbNQu2Ih_-43I8X9f5w7c6sEo7nXacxfWpN6AzT1Ngfj5Bb5Emx5q_7tvwI3JUBpuE35OqBm6sZEdc3ipsVRI3azI85H8F2QX2BfYOaOeUfPI53VJ6LhnyEaTb_8ZNYmTgpIpiAYLLdCWDKR26_Ycbeb0qcaCLmHVyFaUl99_NF3uAL0oVnNywUgStUkuwa8Em-t7cDx9_XEyc_siDy4P_cRzecIoyMwSAvmhTFVYsCRQPk26YSCjLBR-UEjhSYp6GE1NqeJ8nBYyC7NIRJkgAHsf1nWp5QNAX8WKmwJcEfMiVggW-ywjfJRkjMJWKRx4PnzrvOq4PPKOtTnIzfDndvgd2B7UIO_tuckDQpGkYXR04NnyMo26WV4ptCxbI2OWMJNxFDqw1anP8jGh6bAfpw68skrwl-fnk9nBkT17-C_CT-H6h_1p_u7g8O0juBkQ9Opyy7dhfVG38jFBpwV7Yi3kFwJjFyM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chiral+separation+of+propranolol+by+electrokinetic+chromatography+using+nanodiamonds+and+human+serum+albumin+as+a+pseudo%E2%80%90stationary+phase+in+river+water&rft.jtitle=Chirality+%28New+York%2C+N.Y.%29&rft.au=Lanaro%2C+Ver%C3%B3nica+M.&rft.au=Sombra%2C+Lorena+L.&rft.au=Altamirano%2C+Jorgelina+C.&rft.au=Almeida%2C+C%C3%A9sar+A.&rft.date=2024-02-01&rft.issn=0899-0042&rft.eissn=1520-636X&rft.volume=36&rft.issue=2&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fchir.23640&rft.externalDBID=10.1002%252Fchir.23640&rft.externalDocID=CHIR23640 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-0042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-0042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-0042&client=summon |